Literature DB >> 8381504

Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

.   

Abstract

Japanese encephalitis (JE) vaccine was available in the United States from 1983 through 1987 on an investigational basis, through travel clinics in collaboration with CDC (1). JE vaccine manufactured by Biken and distributed by Connaught Laboratories, Inc. (Japanese encephalitis virus vaccine, inactivated, JE-VAX), was licensed on December 10, 1992, to meet the needs of increasing numbers of U.S. residents traveling to Asia and to accommodate the needs of the U.S. military.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381504

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  34 in total

1.  Conjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent West Nile encephalitis.

Authors:  Nicholas O Fischer; Ernesto Infante; Tomohiro Ishikawa; Craig D Blanchette; Nigel Bourne; Paul D Hoeprich; Peter W Mason
Journal:  Bioconjug Chem       Date:  2010-06-16       Impact factor: 4.774

2.  Japanese encephalitis vaccine in travellers. Is wider use prudent?

Authors:  T Jelinek; H D Nothdurft
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

3.  Japanese encephalitis in travelers from non-endemic countries, 1973-2008.

Authors:  Susan L Hills; Anne C Griggs; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

4.  VACCINES - WHAT'S NEW?

Authors:  C G Wilson; P L Prasad; K Nagendra
Journal:  Med J Armed Forces India       Date:  2011-07-21

5.  A case series of three US adults with Japanese encephalitis, 2010-2012.

Authors:  Susan L Hills; Juliet Stoltey; Diana Martínez; Paul Y Kim; Heather Sheriff; Ana Zangeneh; Sally R Eilerman; Marc Fischer
Journal:  J Travel Med       Date:  2014-05-26       Impact factor: 8.490

6.  The effect of insecticide-treated mosquito nets (ITMNs) on Japanese encephalitis virus seroconversion in pigs and humans.

Authors:  Prafulla Dutta; Siraj A Khan; Abdul M Khan; Jani Borah; Chandra K Sarmah; Jagadish Mahanta
Journal:  Am J Trop Med Hyg       Date:  2011-03       Impact factor: 2.345

Review 7.  Estimated global incidence of Japanese encephalitis: a systematic review.

Authors:  Grant L Campbell; Susan L Hills; Marc Fischer; Julie A Jacobson; Charles H Hoke; Joachim M Hombach; Anthony A Marfin; Tom Solomon; Theodore F Tsai; Vivien D Tsu; Amy S Ginsburg
Journal:  Bull World Health Organ       Date:  2011-08-03       Impact factor: 9.408

8.  Status epilepticus in encephalitis: a study of clinical findings, magnetic resonance imaging, and response to antiepileptic drugs.

Authors:  J Kalita; P P Nair; U K Misra
Journal:  J Neurovirol       Date:  2008-11-12       Impact factor: 2.643

9.  Balancing the Efficacy and Safety of Vaccines in the Elderly.

Authors:  Ian J Amanna
Journal:  Open Longev Sci       Date:  2012-06-29

10.  The US Food and Drug Administration provides a pathway for licensing vaccines for global diseases.

Authors:  Michael J Brennan
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.